Hexane

Hexane

SCHEMBL148822

CC(=O)O.CCCCCC.CCOCC

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hexane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 1/20 0.46
CES2 O00748 4/20 0.48
AKR1B1 P15121 1/20 0.48
GPR84 Q9NQS5 7/20 0.46
PPARG P37231 7/20 0.46
PPARD Q03181 7/20 0.46
PPARA Q07869 7/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 5/20 0.46
ALDH1A1 P00352 4/20 0.46
PTPN1 P18031 3/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
MEN1 O00255 1/20 0.46
ALOX15 P16050 1/20 0.46
PDE4A P27815 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptane SCHEMBL15662959 0.97 CES2 (0.52) CES2AKR1B1GPR84PPARGPPARD
Hexane SCHEMBL9706708 0.97 CES2 (0.46) CES2AKR1B1GPR84PPARGPPARD
Hexane SCHEMBL5754743 0.92 CES2 (0.50) CES2AKR1B1GPR84PPARGPPARD
Cyclohexane SCHEMBL16097993 0.91 CES2 (0.42) CES2AKR1B1GPR84PPARGPPARD
Octane SCHEMBL29221340 0.89 CES2 (0.54) CES2GPR84PPARGPPARDPPARA
Hexane SCHEMBL438349 0.89 ALDH1A1 (0.61) CES2AKR1B1GPR84PPARGPPARD
Hexane SCHEMBL28126978 0.89 CES2 (0.41) CES2AKR1B1GPR84PPARGPPARD
Ether SCHEMBL28860809 0.89 DNM1 (0.50) CES2AKR1B1TSHRALDH1A1MEN1
Cetyl Alcohol SCHEMBL28004169 0.89 TSHR (0.56) CES2GPR84PPARGPPARDPPARA
Ether SCHEMBL115545 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11976254-B2 Free polyunsaturated fatty acid-containing composition and manufacturing method therefor NISSUI CORPORATION (JP) 2024-05-07 US disclosed
EP-4351362-A1 PRODUCTION OF SATURATED FATS IN MICROBES Nourish Ingredients Pty Ltd (AU) 2024-04-17 EP disclosed
WO-2024050589-A1 COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO disclosed
WO-2024050588-A1 COMPOSITIONS AND METHODS FOR PRODUCING AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO disclosed
WO-2024050591-A1 COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO disclosed
WO-2024050590-A1 COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS Nourish Ingredients Pty Ltd (AU) 2024-03-14 WO disclosed
US-11913006-B2 Plants producing modified levels of medium chain fatty acids Nuseed Global Innovation Ltd. (GB) 2024-02-27 US disclosed
US-11913035-B2 Modified seed oil content by gene editing PIONEER HI-BRED INTERNATIONAL, INC. (US) 2024-02-27 US disclosed
EP-4301162-A1 PRODUCTION OF PHOSPHOLIPIDS IN MICROBES AND USES THEREOF Nourish Ingredients Pty Ltd (AU) 2024-01-10 EP disclosed
US-20230416186-A1 LIPID COMPOSITIONS COMPRISING TRIACYLGLYCEROL WITH LONG-CHAIN POLYUNSATURATED FATTY ACIDS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2023-12-28 US disclosed
WO-1993023392-A1 IMIDAZOLES LINKED TO BICYCLIC HETEROCYCLIC GROUPS FOR THE TREATMENT OF ATHEROSCLEROSIS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-11-25 WO disclosed
WO-1993023381-A1 IMIDAZOLES FOR THE TREATMENT OF ATHEROSCLEROSIS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-11-25 WO disclosed
EP-0565208-A1 DNA fragment encoding OspA of Borrelia burgdorferi, vaccine and diagnostics comprising OspA encoded by the DNA fragment SYMBICOM AB (SE) 1993-10-13 EP disclosed
US-5166214-A Enzyme inhibitors for anticholesterol agents, enzyme inhibitor and cardiovascular disorders DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-11-24 US disclosed
EP-0429645-A4 REDUCING THE SPREAD OF INFECTION BY BLOOD HANDLING EQUIPMENT 1992-05-13 EP disclosed
EP-0465423-A2 Antimicrobial fatty compositions Research Foundation for Mental Hygiene, Inc. (US) 1992-01-08 EP disclosed
EP-0429645-A1 REDUCING THE SPREAD OF INFECTION BY BLOOD HANDLING EQUIPMENT Research Foundation for Mental Hygiene, Inc. (US) 1991-06-05 EP disclosed
WO-1990015601-A1 REDUCING THE SPREAD OF INFECTION BY BLOOD HANDLING EQUIPMENT RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. (US) 1990-12-27 WO disclosed
EP-0161114-A2 Compounds and compositions influential on the growth and yield of plants UNILEVER N.V. (NL) 1985-11-13 EP disclosed
US-4101588-A HYDROFORMYLATION, CATALYST CONTAINING RHODIUM, CARBON MONOXIDE AND A TERTIARY PHOSPHINE OR PHOSPHITE BASF AKTIENGESELLSCHAFT (DE) 1978-07-18 US disclosed